CAH Stock Tickeron detected bullish Stock Pattern: Broadening Top CAH on March 17, 2025, netting in a 3.04% gain over 1 week

GET DAILY SIGNALS

Get AI intraday signals

CAH - Cardinal Health

Ticker: CAH

Company: Cardinal Health

Gain: +3.04%

Confirmed: 03/17/25

Succeeded: 03/26/25

Total length: 9 days

CAH in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 10, 2025

CAH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where CAH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 17, 2025. You may want to consider a long position or call options on CAH as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CAH just turned positive on March 17, 2025. Looking at past instances where CAH's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

CAH moved above its 50-day moving average on March 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in of 362 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.077) is normal, around the industry mean (7.608). P/E Ratio (44.468) is within average values for comparable stocks, (28.511). CAH's Projected Growth (PEG Ratio) (0.329) is slightly lower than the industry average of (4.521). Dividend Yield (0.018) settles around the average of (0.032) among similar stocks. P/S Ratio (0.131) is also within normal values, averaging (33.632).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.